IRIS UniCatt

La Regina, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 663
NA - Nord America 610
EU - Europa 593
SA - Sud America 146
AF - Africa 19
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.034
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 591
SG - Singapore 322
DE - Germania 144
CN - Cina 138
BR - Brasile 118
SE - Svezia 99
IT - Italia 98
FR - Francia 71
FI - Finlandia 68
VN - Vietnam 61
JP - Giappone 25
GB - Regno Unito 22
IN - India 22
HK - Hong Kong 20
ID - Indonesia 20
NL - Olanda 20
IE - Irlanda 18
RU - Federazione Russa 15
AR - Argentina 11
MX - Messico 10
BD - Bangladesh 9
KR - Corea 8
CO - Colombia 6
PL - Polonia 6
CA - Canada 5
CZ - Repubblica Ceca 5
TR - Turchia 5
UA - Ucraina 5
ZA - Sudafrica 5
ES - Italia 4
IQ - Iraq 4
PK - Pakistan 4
VE - Venezuela 4
AT - Austria 3
EC - Ecuador 3
EG - Egitto 3
JO - Giordania 3
KE - Kenya 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BE - Belgio 2
MA - Marocco 2
MM - Myanmar 2
NO - Norvegia 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
TN - Tunisia 2
UZ - Uzbekistan 2
AL - Albania 1
AU - Australia 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
UG - Uganda 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.034
Salva come PNG Salva come JPEG
Città #
Singapore 165
San Jose 114
Munich 104
Chandler 61
Ashburn 60
Helsinki 51
Beijing 32
Rome 32
Hefei 25
Tokyo 24
Los Angeles 20
Frankfurt am Main 19
Jakarta 19
Lauterbourg 19
Dublin 18
Ho Chi Minh City 18
Hong Kong 18
Council Bluffs 17
Hanoi 16
Hyderabad 15
New York 13
Boston 12
Bologna 11
Moscow 11
San Mateo 11
St Louis 10
Princeton 9
Seoul 8
São Paulo 8
Düsseldorf 7
Kent 7
Milan 7
Paris 7
Turku 7
Aprilia 6
Lappeenranta 6
London 6
Portsmouth 6
Houston 5
Warsaw 5
Amsterdam 4
Andover 4
Augusta 4
Bexley 4
Brooklyn 4
Buffalo 4
Johannesburg 4
Nuremberg 4
Santa Clara 4
São Gonçalo 4
The Dalles 4
Ankara 3
Belo Horizonte 3
Bogotá 3
Brno 3
Cairo 3
Campinas 3
Chicago 3
Curitiba 3
Da Nang 3
Dallas 3
Goiânia 3
Haiphong 3
Mexico City 3
Nairobi 3
North Bergen 3
Orem 3
Poplar 3
Rancho Palos Verdes 3
Santos 3
Seattle 3
Shanghai 3
Wattenheim 3
Atlanta 2
Baku 2
Betim 2
Brasília 2
Brussels 2
Buenos Aires 2
Can Tho 2
Cattolica 2
Charleston 2
Chennai 2
Columbus 2
Draper 2
Erbil 2
Florianópolis 2
Franca 2
Guangzhou 2
Guayaquil 2
Hangzhou 2
Irpin 2
Jyväskylä 2
Karachi 2
Kyiv 2
Limeira 2
Limido Comasco 2
Milwaukee 2
Montreal 2
Muscat 2
Totale 1.173
Salva come PNG Salva come JPEG
Nome #
Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment 240
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells 104
Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as an Anticancer Agent 103
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains 99
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells 98
Small molecule inhibitors of kdm5 histone demethylases increase the radiosensitivity of breast cancer cells overexpressing JARID1B 98
Design, synthesis and biological evaluation of PDZ1 targeting NHERF1 inhibitors as anticancer agents 95
Induction of Ferroptosis in Glioblastoma and Ovarian Cancers by a New Pyrrole Tubulin Assembly Inhibitor 94
Development of N-(4-(1H-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability 92
Anticancer Activity of (S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((pyridin-4-ylmethyl)amino)propan-2-yl)-1H-indole-2-carboxamide (RS4690), a New Dishevelled 1 Inhibitor 88
New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors 88
Emerging Direct Targeting β-Catenin Agents 88
Targeting CBP and p300: Emerging Anticancer Agents 87
Drug design and synthesis of new indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors 86
Drug design and synthesis of new indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors 83
Indolylarylsulfones as novel potent anti-HIV-1 agents 83
Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents 82
RS6077 induces mitotic arrest and selectively activates cell death in human cancer cell lines and in a lymphoma tumor in vivo 79
Indolylarylsulfones as novel potent anti-HIV-1 agents 78
Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy 75
Targeting the Grb2 cSH3 domain: Design, synthesis and biological evaluation of the first series of modulators 73
Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities 66
Totale 2.079
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.007
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202284 0 0 0 0 0 0 0 41 3 1 24 15
2022/2023191 37 21 16 6 25 17 9 23 26 0 8 3
2023/2024127 3 26 3 5 5 10 1 2 13 5 33 21
2024/2025675 13 4 27 33 50 47 100 43 93 86 109 70
2025/20261.002 137 52 60 128 150 58 164 65 101 87 0 0
Totale 2.079